Conference abstract · 7 Dec 2015
Conference abstractPublished 13 Mar 2017
Nanoparticles-in-vaginal films for combined delivery of anti-HIV microbicide drugs
University of Porto, Portugal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: There is an urgent need to reinforce battle against HIV/AIDS, namely by investing more in preventing new infections. Scientific and medical evidence produced over recent years supports that both oral and topical pre-exposure prophylaxis (PrEP) are promising approaches that can reduce sexual transmission of the virus. Still, antiretrovirals with different physicochemical properties may be challenging to combine in one single microbicide product. Methodology & Theoretical Orientation: We propose a new system comprising the incorporation of nanoparticles (NPs) into films for the combined vaginal delivery of hydrophobic/hydrophilic molecules. EFV-loaded poly(lactic-co-glycolic acid) NPs were incorporated alongside free TFV into fast desintegrating films during film manufacturing. The delivery system was characterized for physicochemical properties, as well as for genital distribution, local and systemic 24 h pharmacokinetics, and safety upon intravaginal administration to mice. Findings: EFV NPs with diameter of 145 nm were incorporated into a film with TFV. The film was soft and flexible. Disintegration time in simulated vaginal fluid was 9 min, resulting in dispersions with osmolality values near physiologic and pH of 4.24±0.02. The film presented low toxicity to CaSki, HEC-1-A and HeLa cells. NPs were evenly distributed and retained upon vaginal administration to mice. Mild epithelial penetration of NPs was observed. Drug concentrations in vaginal lavages and tissues peaked rapidly after film administration but slowly decreased up to 24h. Still, drug concentrations were maintained at potentially protective levels. Films were found safe after once daily 14-day administration as assessed by histological observation and analysis of IL-1b, IL-6, KC and TNFα levels. Conclusion & Significance: The proposed NPs-in-vaginal film is a promising new system that can adequately combine microbicide drugs with different solubility profiles. Results support that the system may be safe and able to provide sustained and potentially effective drug levels for preventing vaginal HIV transmission.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Mar 2016
Drug delivery strategies aimed at improving bioavailability and bio-distribution of anti-HIV chemotherapy
Research article · 2014
Pharmacokinetics and Safety Assessment of Anti-HIV Dapivirine Vaginal Microbicide Rings with Multiple Dosing
Conference abstract · 26 Jun 2018
ChAgNPs modified SPGE: Voltammetric estimation of anti-HIV drug
Research article · 21 Sep 2016
Prediction of the Partition coefficient of Some anti-HIV drugs by Density Functional Theory
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectInfectious Diseases
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bruno Sarmento”
